Israel's Itamar gets FDA nod for PAT technology
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale Itamar Medical's easy-to-use, noninvasive, finger-mounted device for use in conjunction with an ECG stress test to detect myocardial ischaemia. The ETT-PAT 2000 device can significantly increase the sensitivity of an ECG stress test, allowing doctors to diagnose disease earlier and more accurately, claims the Caesarea, Israel company.